NEW YORK (GenomeWeb News) - Bio-Rad Laboratories said today that it has closed its acquisition of antibody manufacturer AbD Serotec, a division of MorphoSys, for around €53 million ($70 million) in cash.
NEW YORK (GenomeWeb News) – Bio-Rad Laboratories announced yesterday that it has signed a definitive agreement to acquire antibody manufacturer AbD Serotec for €53 million ($69.7 million) in cash.
NEW YORK (GenomeWeb News) – LifeMap Sciences today announced an exclusive distribution deal with ProSpec-Tany TechnoGene to offer more than 1,000 recombinant proteins and antibodies.
Arrowhead Research said this week that it has signed a deal under which an undisclosed Merck subsidiary will evaluate a novel therapeutic monoclonal antibody candidate developed through its human-derived peptide targeting and discovery program.
NEW YORK (GenomeWeb News) – Life Technologies has struck a collaborative partnership with the Structural Genomics Consortium to develop and release 200 highly specific epigenetic recombinant antibodies, the company said today.
While the company does not anticipate using the approach to develop RNAi-based drugs itself, it hopes that it will be able to out-license the technology to a partner interested in taking it forward into the clinic.
City of Hope will then use Affomix's recombinant antibodies to generate proteomic profiles characteristic of a number of cancers, such as renal and prostate.
